Aspira Pathlab & Diagnostics Limited

BSE: 540788
Aspira Pathlab & Diagnostics Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L85100MH1973PLC289209 Incorporated 03 July 1973 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 540788 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹24.98 Cr
▲ 13.56% YoY
Computed EBITDA · FY 2026
₹1.98 Cr
▼ 49.43% YoY
Net profit · FY 2026
₹5.13 Lakh
▼ 97.52% YoY
Authorised capital
₹35 Cr
Registered with MCA
Paid-up capital
₹15.79 Cr
Issued & subscribed
Open charges
None
Satisfied ₹6.22 Cr
Company age
53 yrs
Est. 1973
Employees · EPFO
70
Latest available

About Aspira Pathlab & Diagnostics Limited

Data last updated: 14 July 2026

Aspira Pathlab & Diagnostics Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 03 July 1973, the company has been in operation for over 53 years.

Registered with ROC Mumbai under CIN L85100MH1973PLC289209. Listed on BSE: 540788.

Capital: an authorised share capital of ₹35 Cr and a paid-up capital of ₹15.79 Cr. Formerly known as Utkal Soap Products Ltd and Industrial Gas & Steel Products (India) Limited. It is led by directors including Pankaj Jashwant Shah and Nikunj Velji Mange.

Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹24.98 Cr, a growth of 13.56% compared to the previous year. The net worth stands at ₹12.23 Cr (up 0.12% YoY). Total assets are valued at ₹18.51 Cr (up 5.68% YoY).

The company has a workforce of approximately 70 employees as per the latest available data.

The company is associated with 1 brand - Aspira Diagnostics. As per MCA filings, the company has satisfied charges of ₹6.22 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aspiradiagnostics.com.

Company Details of Aspira Pathlab & Diagnostics Limited
CIN L85100MH1973PLC289209
Registration Number 289209
Incorporation Date 03 July 1973
ROC Mumbai
Listing Status Listed (BSE: 540788)
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Pankaj Jashwant Shah Managing Director Nikunj Velji Mange Director Haseeb Ahmad Drabu Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    aspiradiagnostics.com
  • Social Media
  • Apps
  • Registered Address
    Flat No.2 R.D. Shah Bldg Shraddhanand Road Opp. Ghatkopar Railway Station Ghatkopa, R (West), Mumbai, Maharashtra, India – 400086
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs
Company report
Aspira Pathlab & Diagnostics Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Aspira Pathlab & Diagnostics Limited report

Financials, compliance, directors, charges, ownership and filings for Aspira Pathlab & Diagnostics Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Aspira Pathlab & Diagnostics Limited

Aspira Pathlab & Diagnostics Limited has undergone 3 name changes throughout its history. The company was previously known as Utkal Soap Products Ltd, Industrial Gas & Steel Products (India) Limited, and Utkal Soap Products Limited. The current legal name is Aspira Pathlab & Diagnostics Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Aspira Pathlab & Diagnostics Limited Current
Utkal Soap Products Ltd Previous
Industrial Gas & Steel Products (India) Limited Previous
Utkal Soap Products Limited Previous

CIN History of Aspira Pathlab & Diagnostics Limited

Aspira Pathlab & Diagnostics Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85100MH1973PLC289209, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L85100MH1973PLC289209 Current
L51909WB1973PLC028878 Previous
L85100WB1973PLC028878 Previous

Associated Brands with Aspira Pathlab & Diagnostics Limited

Aspira Pathlab & Diagnostics Limited operates one associated brand: Aspira Diagnostics. These brands represent Aspira Pathlab & Diagnostics Limited's diversified market presence and brand portfolio.

Brand Description Website
Aspira Diagnostics
Pathology lab services are operated through a chain of facilities. aspiradiagnostics.com

Competitors & Alternatives of Aspira Pathlab & Diagnostics Limited

Brands and companies operating in the same space as Aspira Pathlab & Diagnostics Limited include Dr Lal PathLabs, Redcliffe Labs, Metropolis India and 5 more.

Competitor Description Location Founded
Dr Lal PathLabs Dr Lal PathLabs Chain of pathology and radiology labs Gurugram, India, India 1949
Redcliffe Labs Redcliffe Labs Home-based diagnostic tests are booked via an online platform. Noida, India, India 2018
Metropolis India Metropolis India Diagnostic centers are operated as a nationwide chain. Mumbai, India, India 1981
Orange health Orange health At-home diagnostic tests are booked and collected by phlebotomists. Bengaluru, India, India 2020
Agilus Diagnostics Agilus Diagnostics Leading diagnostic chain providing quality blood test and full body checkup services Gurugram, India, India 1995
Apollo Diagnostics Apollo Diagnostics Provides pathology lab tests, health check packages, and home sample collection. Hyderabad, India, India 2015
Sterling Accuris Diagnostics Sterling Accuris Diagnostics Pathology diagnostic services are offered via a chain of labs. Ahmedabad, India, India 2015
Airmed Airmed Provider of a chain of diagnostic labs Ahmedabad, India, India 2016

Business Activity of Aspira Pathlab & Diagnostics Limited

Aspira Pathlab & Diagnostics Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including medical and dental practice, nursing, pathology, blood bank services, etc..

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q2 Medical and dental practice, Nursing, pathology, blood bank services, etc. Locked
Premium access

Business activity turnover details for Aspira Pathlab & Diagnostics Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Aspira Pathlab & Diagnostics Limited

Aspira Pathlab & Diagnostics Limited is audited by Sarda Soni Associates LLP (ICAI peer reviewed, certificate valid till 2026-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Sarda Soni Associates LLP (ICAI peer reviewed, certificate valid till 2026-10-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Aspira Pathlab & Diagnostics Limited

Aspira Pathlab & Diagnostics Limited is currently managed by 5 directors, with 26 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Pankaj Jashwant Shah
Also directs: Aspira Pathlab & Diagnostics Limited, Aspira Dna Diagnostics Gujarat Llp
Managing Director 01 Aug 2016 10 Years 0 Months Current
Nikunj Velji Mange
Also directs: Aspira Pathlab & Diagnostics Limited, Growfresh Agro Venture Llp, Ybl Properties Llp
Director 29 Aug 2020 5 Years 11 Months Current
Haseeb Ahmad Drabu
Also directs: Aspira Pathlab & Diagnostics Limited, Essar Power Limited, Essar Ports & Logistics Limited and 5 more
Director 27 Oct 2018 7 Years 9 Months Current
Kiran Raghavendra Awasthi
Also directs: Aspira Pathlab & Diagnostics Limited, Raj Oil Mills Limited
Director 12 Nov 2025 0 Years 9 Months Current
Manas Rajendra Mengar
Also directs: Aspira Pathlab & Diagnostics Limited
Director 12 Aug 2023 3 Years 0 Months Current
View all directors

Financials of Aspira Pathlab & Diagnostics Limited FY 2026 filings available

Aspira Pathlab & Diagnostics Limited reported revenue of ₹24.98 Cr (up 13.56% YoY) for FY 2026.

Revenue · FY 2026
₹24.98 Cr ▲ 13.56%
Profit · FY 2026
₹5.13 Lakh ▼ 97.52%
Computed EBITDA · FY 2026
₹1.98 Cr ▼ 49.43%
Revenue₹ Cr · Standalone0102030FY 2019: ₹8 Cr7.6FY 2019FY 2020: ₹8 Cr · +10.2% YoY8.4+10.2%FY 2020FY 2021: ₹15 Cr · +80.7% YoY15.2+80.7%FY 2021FY 2022: ₹20 Cr · +28.5% YoY19.5+28.5%FY 2022FY 2023: ₹14 Cr · -26% YoY14.5-26%FY 2023FY 2024: ₹13 Cr · -8.7% YoY13.2-8.7%FY 2024FY 2025: ₹22 Cr · +66.6% YoY22+66.6%FY 2025FY 2026: ₹25 Cr · +13.6% YoY25+13.6%FY 2026
Net Profit₹ Cr · Standalone-6-4-20246FY 2019: ₹5 Cr (loss)-5.2FY 2019FY 2020: ₹4 Cr (loss) · +18.2% YoY-4.2FY 2020FY 2021: ₹1 Cr · +132.6% YoY1.4+132.6%FY 2021FY 2022: ₹4 Cr · +222.9% YoY4.5+222.9%FY 2022FY 2023: ₹0 Cr (loss) · -102% YoY-0.1FY 2023FY 2024: ₹3 Cr (loss) · -2912.6% YoY-2.7FY 2024FY 2025: ₹2 Cr · +177.6% YoY2.1+177.6%FY 2025FY 2026: ₹0 Cr · -97.5% YoY0.1-97.5%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0510Q1'25: ₹5 Cr4.6Q1'25Q2'25: ₹6 Cr6.2Q2'25Q3'25: ₹5 Cr5.4Q3'25Q4'25: ₹6 Cr5.8Q4'25Q1'26: ₹5 Cr · +13.2% YoY5.2+13.2%Q1'26Q2'26: ₹8 Cr · +31% YoY8.1+31%Q2'26Q3'26: ₹5 Cr · -5.3% YoY5.1-5.3%Q3'26Q4'26: ₹7 Cr · +12.9% YoY6.5+12.9%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹24.98 Cr ₹22 Cr ₹13.2 Cr ₹14.46 Cr ₹19.54 Cr ₹15.21 Cr ₹8.42 Cr ₹7.64 Cr
Other Income ₹51.59 Lakh ₹38.89 Lakh ₹42.11 Lakh ₹32.09 Lakh ₹10.29 Lakh ₹20.38 Lakh ₹28.8 Lakh ₹25.32 Lakh
Total Income ₹25.5 Cr ₹22.39 Cr ₹13.63 Cr ₹14.78 Cr ₹19.64 Cr ₹15.41 Cr ₹8.7 Cr ₹7.89 Cr
Cost of Materials Consumed ₹4.52 Cr ₹3.7 Cr ₹2.62 Cr ₹2.5 Cr ₹3.14 Cr ₹2.63 Cr ₹1.99 Cr ₹2.26 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹8.78 Cr ₹7.33 Cr ₹6.2 Cr ₹5.59 Cr ₹5.02 Cr ₹4.03 Cr ₹4.95 Cr ₹4.47 Cr
Finance Costs ₹38.94 Lakh ₹34.74 Lakh ₹36.77 Lakh ₹41.72 Lakh ₹37.27 Lakh ₹89.15 Lakh ₹1.01 Cr ₹96.07 Lakh
Depreciation & Amortisation ₹1.54 Cr ₹1.49 Cr ₹1.54 Cr ₹1.59 Cr ₹1.64 Cr ₹1.44 Cr ₹1.66 Cr ₹1.23 Cr
Other Expenses ₹10.22 Cr ₹7.45 Cr ₹5.57 Cr ₹4.77 Cr ₹5.02 Cr ₹5.03 Cr ₹3.34 Cr ₹4.15 Cr
Total Expenses ₹25.45 Cr ₹20.32 Cr ₹16.3 Cr ₹14.87 Cr ₹15.19 Cr ₹14.03 Cr ₹12.95 Cr ₹13.07 Cr
Profit Before Exceptional Items & Tax ₹5.13 Lakh ₹2.07 Cr -₹2.67 Cr -₹8.87 Lakh ₹4.46 Cr ₹1.38 Cr -₹4.24 Cr -₹5.18 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹5.13 Lakh ₹2.07 Cr -₹2.67 Cr -₹8.87 Lakh ₹4.46 Cr ₹1.38 Cr -₹4.24 Cr -₹5.18 Cr
Total Tax Expense ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Net Profit ₹5.13 Lakh ₹2.07 Cr -₹2.67 Cr -₹8.87 Lakh ₹4.46 Cr ₹1.38 Cr -₹4.24 Cr -₹5.18 Cr
Other Comprehensive Income ₹6.12 Lakh ₹4,000 ₹6.51 Lakh ₹4.96 Lakh ₹1.55 Lakh ₹13.27 Lakh -₹1 Lakh ₹97,000
Total Comprehensive Income ₹11.25 Lakh ₹2.07 Cr -₹2.61 Cr -₹3.91 Lakh ₹4.47 Cr ₹1.51 Cr -₹4.25 Cr -₹5.17 Cr
EBITDA (computed) ₹1.98 Cr ₹3.91 Cr -₹76.57 Lakh ₹1.91 Cr ₹6.47 Cr ₹3.72 Cr -₹1.57 Cr -₹2.99 Cr
Basic EPS ₹0.05 ₹2.01 ₹2.60 ₹-0.09 ₹4.33 ₹1.59 ₹-4.56 ₹-6.31
Diluted EPS ₹0.05 ₹2.01 ₹2.60 ₹-0.09 ₹4.33 ₹1.59 ₹-4.95 ₹-7.40
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹18.51 Cr ₹17.51 Cr ₹14.71 Cr ₹17.34 Cr ₹18.14 Cr ₹11.78 Cr ₹14.34 Cr ₹14.8 Cr
Non-current Assets ₹13.92 Cr ₹12.15 Cr ₹10.35 Cr ₹11.49 Cr ₹10.99 Cr ₹7.9 Cr ₹11.05 Cr ₹12.5 Cr
Current Assets ₹4.59 Cr ₹5.36 Cr ₹4.36 Cr ₹5.86 Cr ₹7.14 Cr ₹3.88 Cr ₹3.29 Cr ₹2.3 Cr
Property, Plant & Equipment ₹3.88 Cr ₹3.86 Cr ₹4.12 Cr ₹5.31 Cr ₹6.82 Cr ₹4.96 Cr ₹5.03 Cr ₹6.19 Cr
Inventories ₹69.72 Lakh ₹51.13 Lakh ₹44.72 Lakh ₹39.89 Lakh ₹40.45 Lakh ₹36.67 Lakh ₹27.65 Lakh ₹28.01 Lakh
Trade Receivables ₹1.73 Cr ₹2.35 Cr ₹2.24 Cr ₹2.34 Cr ₹4.49 Cr ₹1.7 Cr ₹60.46 Lakh ₹79.61 Lakh
Cash & Equivalents ₹1.26 Cr ₹1.75 Cr ₹80.38 Lakh ₹56.66 Lakh ₹1.35 Cr ₹1.19 Cr ₹9.65 Lakh ₹9.64 Lakh
Equity (Net Worth) ₹12.23 Cr ₹12.22 Cr ₹10.14 Cr ₹12.75 Cr ₹12.79 Cr ₹8.31 Cr ₹3.8 Cr ₹5.19 Cr
Equity Share Capital ₹10.29 Cr ₹10.29 Cr ₹10.29 Cr ₹10.29 Cr ₹10.29 Cr ₹10.29 Cr ₹9.29 Cr ₹8.19 Cr
Borrowings (Non-current) ₹1.35 Cr ₹1.21 Cr ₹1.08 Cr ₹96.18 Lakh ₹85.87 Lakh ₹76.67 Lakh ₹4.55 Cr ₹4.78 Cr
Borrowings (Current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹2.32 Cr ₹1.96 Cr
Total Debt (computed) ₹1.35 Cr ₹1.21 Cr ₹1.08 Cr ₹96.18 Lakh ₹85.87 Lakh ₹76.67 Lakh ₹6.87 Cr ₹6.75 Cr
Current Liabilities ₹3.11 Cr ₹2.37 Cr ₹2.07 Cr ₹1.58 Cr ₹1.79 Cr ₹2.01 Cr ₹5.12 Cr ₹4.21 Cr
Total Liabilities ₹6.27 Cr ₹5.3 Cr ₹4.57 Cr ₹4.59 Cr ₹5.35 Cr ₹3.46 Cr ₹10.53 Cr ₹9.61 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹1.45 Cr ₹1.88 Cr ₹1.05 Cr -₹1.21 Lakh ₹2.03 Cr
Investing Cash Flow -₹80.43 Lakh ₹6.58 Lakh ₹13.83 Lakh ₹15.94 Lakh -₹51.23 Lakh
Financing Cash Flow -₹1.14 Cr -₹99.41 Lakh -₹95.41 Lakh -₹93.5 Lakh -₹1.35 Cr
Capital Expenditure ₹69.57 Lakh ₹34.43 Lakh ₹26.18 Lakh ₹13.13 Lakh ₹59.86 Lakh
Free Cash Flow (computed) ₹75.79 Lakh ₹1.53 Cr ₹79.12 Lakh -₹14.34 Lakh ₹1.43 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹48.79 Lakh ₹94.86 Lakh ₹23.72 Lakh -₹78.77 Lakh ₹16.67 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹6.52 Cr ₹5.12 Cr ₹8.09 Cr ₹5.25 Cr ₹5.78 Cr ₹5.41 Cr ₹6.18 Cr ₹4.64 Cr
Other Income ₹13.92 Lakh ₹12.95 Lakh ₹13.95 Lakh ₹10.77 Lakh ₹13.04 Lakh ₹8.86 Lakh ₹7.58 Lakh ₹9.18 Lakh
Total Income ₹6.66 Cr ₹5.25 Cr ₹8.23 Cr ₹5.36 Cr ₹5.91 Cr ₹5.5 Cr ₹6.25 Cr ₹4.73 Cr
Cost of Materials Consumed ₹1.22 Cr ₹1.12 Cr ₹1.28 Cr ₹89.6 Lakh ₹86.95 Lakh ₹84.89 Lakh ₹1.1 Cr ₹88.03 Lakh
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹2.29 Cr ₹2.45 Cr ₹2.15 Cr ₹1.89 Cr ₹1.94 Cr ₹1.97 Cr ₹1.75 Cr ₹1.66 Cr
Finance Costs ₹9.97 Lakh ₹9.81 Lakh ₹9.76 Lakh ₹9.4 Lakh ₹9.32 Lakh ₹9.41 Lakh ₹7.89 Lakh ₹8.12 Lakh
Depreciation & Amortisation ₹39.54 Lakh ₹38.23 Lakh ₹39.55 Lakh ₹36.52 Lakh ₹36.74 Lakh ₹38.59 Lakh ₹36.39 Lakh ₹37.66 Lakh
Other Expenses ₹3.35 Cr ₹2.76 Cr ₹2.47 Cr ₹1.64 Cr ₹1.91 Cr ₹1.82 Cr ₹1.97 Cr ₹1.75 Cr
Total Expenses ₹7.35 Cr ₹6.81 Cr ₹6.4 Cr ₹4.89 Cr ₹5.18 Cr ₹5.12 Cr ₹5.26 Cr ₹4.75 Cr
Profit Before Exceptional Items & Tax -₹68.91 Lakh -₹1.56 Cr ₹1.84 Cr ₹46.94 Lakh ₹72.33 Lakh ₹37.66 Lakh ₹99.03 Lakh -₹1.67 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹68.91 Lakh -₹1.56 Cr ₹1.84 Cr ₹46.94 Lakh ₹72.33 Lakh ₹37.66 Lakh ₹99.03 Lakh -₹1.67 Lakh
Total Tax Expense ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Net Profit -₹68.91 Lakh -₹1.56 Cr ₹1.84 Cr ₹46.94 Lakh ₹72.33 Lakh ₹37.66 Lakh ₹99.03 Lakh -₹1.67 Lakh
Other Comprehensive Income ₹6.12 Lakh ₹0 ₹0 ₹0 ₹4,000 ₹0 ₹0 ₹0
Total Comprehensive Income -₹62.79 Lakh -₹1.56 Cr ₹1.84 Cr ₹46.94 Lakh ₹72.37 Lakh ₹37.66 Lakh ₹99.03 Lakh -₹1.67 Lakh
EBITDA (computed) -₹19.4 Lakh -₹1.08 Cr ₹2.33 Cr ₹92.86 Lakh ₹1.18 Cr ₹85.66 Lakh ₹1.43 Cr ₹44.11 Lakh
Basic EPS ₹-0.67 ₹-1.52 ₹1.78 ₹0.46 ₹0.70 ₹0.37 ₹0.96 ₹0.02
Diluted EPS ₹-0.67 ₹-1.52 ₹1.78 ₹0.46 ₹0.70 ₹0.37 ₹0.96 ₹0.02
Latest 8 quarters shown.
Metrics FY 2025
Revenue from Operations ₹22 Cr
Other Income ₹38.89 Lakh
Total Income ₹22.39 Cr
Cost of Materials Consumed ₹3.7 Cr
Purchases of Stock-in-Trade ₹0
Changes in Inventories ₹0
Employee Benefit Expense ₹7.33 Cr
Finance Costs ₹34.74 Lakh
Depreciation & Amortisation ₹1.49 Cr
Other Expenses ₹7.45 Cr
Total Expenses ₹20.32 Cr
Profit Before Exceptional Items & Tax ₹2.07 Cr
Exceptional Items -₹5 Lakh
Profit Before Tax ₹2.02 Cr
Total Tax Expense ₹0
Net Profit ₹2.02 Cr
  attributable to Owners ₹0
  attributable to NCI ₹0
Other Comprehensive Income ₹4,000
Total Comprehensive Income ₹2.02 Cr
EBITDA (computed) ₹3.91 Cr
Basic EPS ₹1.97
Diluted EPS ₹1.97
Metrics FY 2025
Total Assets ₹17.46 Cr
Non-current Assets ₹12.1 Cr
Current Assets ₹5.36 Cr
Property, Plant & Equipment ₹3.86 Cr
Inventories ₹51.13 Lakh
Trade Receivables ₹2.35 Cr
Cash & Equivalents ₹1.75 Cr
Equity (Net Worth) ₹12.17 Cr
Equity Share Capital ₹10.29 Cr
Borrowings (Non-current) ₹1.21 Cr
Borrowings (Current) ₹0
Total Debt (computed) ₹1.21 Cr
Current Liabilities ₹2.37 Cr
Total Liabilities ₹5.3 Cr
Metrics FY 2025
Operating Cash Flow ₹1.83 Cr
Investing Cash Flow ₹11.57 Lakh
Financing Cash Flow -₹99.42 Lakh
Capital Expenditure ₹34.43 Lakh
Free Cash Flow (computed) ₹1.48 Cr
Dividends Paid ₹0
Net Change in Cash ₹94.86 Lakh
Metrics Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹5.25 Cr ₹5.78 Cr ₹5.41 Cr ₹6.18 Cr ₹4.64 Cr
Other Income ₹10.77 Lakh ₹13.05 Lakh ₹8.86 Lakh ₹7.58 Lakh ₹9.18 Lakh
Total Income ₹5.36 Cr ₹5.91 Cr ₹5.5 Cr ₹6.25 Cr ₹4.73 Cr
Cost of Materials Consumed ₹89.6 Lakh ₹86.95 Lakh ₹84.89 Lakh ₹1.1 Cr ₹88.03 Lakh
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹1.89 Cr ₹1.94 Cr ₹1.97 Cr ₹1.75 Cr ₹1.66 Cr
Finance Costs ₹9.4 Lakh ₹9.31 Lakh ₹9.41 Lakh ₹7.89 Lakh ₹8.12 Lakh
Depreciation & Amortisation ₹36.52 Lakh ₹36.74 Lakh ₹38.59 Lakh ₹36.39 Lakh ₹37.66 Lakh
Other Expenses ₹1.64 Cr ₹1.91 Cr ₹1.82 Cr ₹1.97 Cr ₹1.75 Cr
Total Expenses ₹4.89 Cr ₹5.18 Cr ₹5.12 Cr ₹5.26 Cr ₹4.75 Cr
Profit Before Exceptional Items & Tax ₹46.94 Lakh ₹72.34 Lakh ₹37.66 Lakh ₹99.03 Lakh -₹1.67 Lakh
Exceptional Items ₹0 -₹4.28 Lakh -₹7.05 Lakh -₹5,000 ₹0
Profit Before Tax ₹46.94 Lakh ₹68.06 Lakh ₹30.61 Lakh ₹98.98 Lakh -₹1.67 Lakh
Total Tax Expense ₹0 ₹0 ₹0 ₹0 ₹0
Net Profit ₹42.15 Lakh ₹68.06 Lakh ₹30.61 Lakh ₹98.98 Lakh ₹4.71 Lakh
  attributable to Owners - ₹0 - ₹0 ₹0
  attributable to NCI - ₹0 - ₹0 ₹0
Other Comprehensive Income ₹0 ₹4,000 ₹0 ₹0 ₹0
Total Comprehensive Income ₹42.15 Lakh ₹68.1 Lakh ₹30.61 Lakh ₹98.98 Lakh ₹4.71 Lakh
EBITDA (computed) ₹92.86 Lakh ₹1.18 Cr ₹85.66 Lakh ₹1.43 Cr ₹44.11 Lakh
Basic EPS ₹0.41 ₹0.66 ₹0.30 ₹0.96 ₹0.05
Diluted EPS ₹0.41 ₹0.66 ₹0.30 ₹0.96 ₹0.05
Latest 5 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Aspira Pathlab & Diagnostics Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Aspira Pathlab & Diagnostics Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 18.39%, retail and other public shareholders hold 81.61% of Aspira Pathlab & Diagnostics Limited. The company had 1,769 shareholders on record.

Promoters: 18.39%Retail & Others: 81.61%
Mar 2026
QUARTER
18.39% Promoters
81.61% Retail & Others
Promoter holding - history
Now 18.39% · Mar 2026High 19.37% · Jun 2023Low 18.39% · Mar 2025
17%18%19%20%21%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 19.37%Sep 2023: 18.90%Dec 2023: 18.90%Mar 2024: 18.72%Jun 2024: 18.72%Sep 2024: 18.55%Dec 2024: 18.55%Mar 2025: 18.39%Jun 2025: 18.39%Sep 2025: 18.39%Dec 2025: 18.39%Mar 2026: 18.39%19.37%18.39%18.39%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters18.39%18.39%18.39%18.39%18.39%18.55%
Public81.61%81.61%81.61%81.61%81.61%81.45%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters18.39%18.39%18.72%
Public81.61%81.61%81.28%
Promoter change (YoY, %pts)+0.00-0.33-

Charges & Borrowings of Aspira Pathlab & Diagnostics Limited

Open charges
₹0
Satisfied charges
₹6.22 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹6.22 Cr
Latest charge details
DateLenderAmountStatus
19 Jul 2020 Hdfc Bank Limited ₹96.8 Lakh Satisfied
04 Jun 2018 Hdfc Bank Limited ₹50 Lakh Satisfied
07 Dec 2016 Hdfc Bank Limited ₹4.75 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Aspira Pathlab & Diagnostics Limited

Aspira Pathlab & Diagnostics Limited has a workforce of 70 employees as of Dec 20, 2024.

Employee count
70
Active EPFO establishments
1
Employee growth
-2.78%
Premium access

Employee and EPFO history for Aspira Pathlab & Diagnostics Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Aspira Pathlab & Diagnostics Limited

Premium access

GST registrations and filing compliance for Aspira Pathlab & Diagnostics Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Aspira Pathlab & Diagnostics Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Aspira Pathlab & Diagnostics Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Aspira Pathlab & Diagnostics Limited

Premium access

MSME payment history for Aspira Pathlab & Diagnostics Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aspira Pathlab & Diagnostics Limited

Premium access

Corporate group structure for Aspira Pathlab & Diagnostics Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aspira Pathlab & Diagnostics Limited

Premium access

MCA filings and documents for Aspira Pathlab & Diagnostics Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Aspira Pathlab & Diagnostics Limited

Directors
12 Nov 2025
Kiran Raghavendra Awasthi was appointed as a Director on 12 Nov 2025 & has been associated with this company since 9 months 5 days.
Activity
26 Sep 2025
Aspira Pathlab & Diagnostics Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Aspira Pathlab & Diagnostics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
09 Sep 2023
Krupali Kirti Kumar Shah was appointed as a Company Secretary on 09 Sep 2023 & has been associated with this company since 2 years 11 months.
Directors
12 Aug 2023
Manas Rajendra Mengar was appointed as a Director on 12 Aug 2023 & has been associated with this company since 3 years 6 days.
Charges
07 Oct 2021
A charge registered on 07 Dec 2016 via Charge ID 100077364 with Hdfc Bank Limited was fully satisfied on 07 Oct 2021.

Recent News on Aspira Pathlab & Diagnostics Limited

Frequently Asked Questions about Aspira Pathlab & Diagnostics Limited

Aspira Pathlab & Diagnostics Limited is an active public limited company in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 03 July 1973 (53+ years old) and is registered under CIN L85100MH1973PLC289209. Listed on BSE: 540788. The company has 70 employees.

Aspira Pathlab & Diagnostics Limited reported revenue of ₹24.98 Cr for FY 2026 (up 13.56% YoY) based on standalone BSE filings.

The current directors of Aspira Pathlab & Diagnostics Limited are:

The primary industry of Aspira Pathlab & Diagnostics Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.

Yes. Aspira Pathlab & Diagnostics Limited is listed on BSE with code 540788.

Aspira Pathlab & Diagnostics Limited can be reached at the registered office: Flat No.2 R.D. Shah Bldg Shraddhanand Road Opp. Ghatkopar Railway Station Ghatkopa, R West, Mumbai, Maharashtra, India – 400086, or through the website aspiradiagnostics.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available